Annett Boeddrich

EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers

Dagmar E. Ehrnhoefer, Jan Bieschke, Annett Boeddrich et al. · Nature Structural & Molecular Biology · 2008 · 1.4K citations

Off-pathway Oligomers, Protein Assembly, G Protein-coupled Receptor +5

Accumulation of Mutant Huntingtin Fragments in Aggresome-like Inclusion Bodies as a Result of Insufficient Protein Degradation

Stephanie Waelter, Annett Boeddrich, Rudi Lurz et al. · Molecular Biology of the Cell · 2001 · 629 citations

Small-molecule conversion of toxic oligomers to nontoxic β-sheet–rich amyloid fibrils

Jan Bieschke, Martin Herbst, Thomas Wiglenda et al. · Nature Chemical Biology · 2011 · 438 citations

Protein Nanoparticles, Biochemistry, Natural Sciences +4

Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington's disease therapy

Volker Heiser, Eberhard Scherzinger, Annett Boeddrich et al. · Proceedings of the National Academy of Sciences · 2000 · 263 citations · Full text

Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay

Volker Heiser, Sabine Engemann, W. Bröcker et al. · Proceedings of the National Academy of Sciences · 2002 · 206 citations · Full text